EGFL7 and glioblastoma: For example, miR-338-3p inhibits GBM proliferation by targeting MAP4K3 and suppresses angiogenesis by inhibiting EGFL7 (53, 54); miR338-5p was also found to enhance tumor metastasis by inhibiting TSHZ3 expression and thus promoting MMP2 expression (55).